158 related articles for article (PubMed ID: 37355720)
21. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.
Dallal CM; Tice JA; Buist DS; Bauer DC; Lacey JV; Cauley JA; Hue TF; Lacroix A; Falk RT; Pfeiffer RM; Fuhrman BJ; Veenstra TD; Xu X; Brinton LA;
Carcinogenesis; 2014 Feb; 35(2):346-55. PubMed ID: 24213602
[TBL] [Abstract][Full Text] [Related]
22. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
23. Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.
Dalenc F; Iuliano L; Filleron T; Zerbinati C; Voisin M; Arellano C; Chatelut E; Marquet P; Samadi M; Roché H; Poirot M; Silvente-Poirot S
J Steroid Biochem Mol Biol; 2017 May; 169():210-218. PubMed ID: 27343991
[TBL] [Abstract][Full Text] [Related]
24. Associations of sex steroid hormones with mortality in women with breast cancer.
Duggan C; Stanczyk F; Campbell K; Neuhouser ML; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard R; McTiernan A
Breast Cancer Res Treat; 2016 Feb; 155(3):559-67. PubMed ID: 26865065
[TBL] [Abstract][Full Text] [Related]
25. Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women.
Luo Y; Li HB; Zhang Y; Wu YX; Shen D; Che YQ
Front Endocrinol (Lausanne); 2021; 12():766463. PubMed ID: 34970222
[TBL] [Abstract][Full Text] [Related]
26. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
[TBL] [Abstract][Full Text] [Related]
27. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
[TBL] [Abstract][Full Text] [Related]
28. Fast liquid chromatography-mass spectrometry reveals side chain oxysterol heterogeneity in breast cancer tumour samples.
Solheim S; Hutchinson SA; Lundanes E; Wilson SR; Thorne JL; Roberg-Larsen H
J Steroid Biochem Mol Biol; 2019 Sep; 192():105309. PubMed ID: 30779932
[TBL] [Abstract][Full Text] [Related]
29. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
30. Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women.
Kabat GC; Kim M; Phipps AI; Li CI; Messina CR; Wactawski-Wende J; Kuller L; Simon MS; Yasmeen S; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2011 May; 22(5):775-83. PubMed ID: 21360045
[TBL] [Abstract][Full Text] [Related]
31. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
32. Associations between lifestyle, health, and clinical characteristics and circulating oxysterols and cholesterol precursors in women diagnosed with breast cancer: a cross-sectional study.
Decker NS; Johnson T; Le Cornet C; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
Sci Rep; 2024 Feb; 14(1):4977. PubMed ID: 38424253
[TBL] [Abstract][Full Text] [Related]
33. Effect of estradiol as a continuous variable on breast cancer survival by menopausal status: a cohort study in China.
Li J; Li C; Feng Z; Liu L; Zhang L; Kang W; Liu Y; Ma B; Li H; Huang Y; Zheng H; Song F; Song F; Chen K
Breast Cancer Res Treat; 2022 Jul; 194(1):103-111. PubMed ID: 35467315
[TBL] [Abstract][Full Text] [Related]
34. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
35. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
[TBL] [Abstract][Full Text] [Related]
36. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
37. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
38. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.
Nechuta S; Chen WY; Cai H; Poole EM; Kwan ML; Flatt SW; Patterson RE; Pierce JP; Caan BJ; Ou Shu X
Int J Cancer; 2016 May; 138(9):2088-97. PubMed ID: 26606746
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
[TBL] [Abstract][Full Text] [Related]
40. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes.
Lappano R; Recchia AG; De Francesco EM; Angelone T; Cerra MC; Picard D; Maggiolini M
PLoS One; 2011 Jan; 6(1):e16631. PubMed ID: 21304949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
